Data Management And Sharing System of China National Clinical Research Center for Neurological Diseases
Clinical Features, Intradural Transcavernous Surgical Management, and Outcomes of Giant Cavernous Sinus Hemangiomas: A Single-Institution Experience
First author：Li Huan,Zhang Bin, Wang Wei
Corresponding author：Liu Bai-Yun
essential_information
- Person in charge：Li Huan,Zhang Bin, Wang Wei
- Data Sources： OTHERS
- Number of papers：OTHERS20190853
- Published time：2019-02-05
2019-02-05
Published articles
Journal：World Neurosurgery
Publication type: Original Article
IF(IF): 2.104
PMID: 30735865 Link To Pubmed Full text Download
Background And Purpose
Method
Between January 2012 and January 2017, 15 patients with giant CSHs were treated surgically. All cases were evaluated with a contrast-enhanced magnetic resonance imaging scan and confirmed histopathologically. A complete intradural approach was used for all patients. Clinical manifestations, radiographic characteristics, operative techniques, and outcomes of patients were analyzed.
Conclusion
Surgical total resection is the primary and reasonable choice for giant CSHs. Microsurgical resection of giant CSHs through a completely intradural transcavernous approach is an alternative treatment option for giant CSHs.
Main results
Headache was the most common initial symptom, followed by decreased visual acuity and diplopia. Postoperative magnetic resonance imaging showed that gross total resection was achieved in 13 patients. Two patients had experienced total ipsilateral visual loss for several years before surgery; vision improved in all remaining patients with preoperative visual diminution. The most common early neurologic deficit was cranial nerve VI dysfunction, which was observed in 9 patients (60%; 5 new deficits). Only 2 patients (13.3%) experienced permanent morbidity on long-term follow-up. The early postoperative morbidity rate for cranial nerve III dysfunction was 33.3% (5 patients), and only 1 patient (6.7%) experienced permanent morbidity. Four patients (26.7%) had slight postoperative facial numbness.